SCHEMBL17157612

SCHEMBL17157612

O=C(Cl)/C=C/c1ccc(F)c(Br)c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAOB P27338 5/20 0.59
▸ MAOA P21397 4/20 0.59
▸ VCP P55072 1/20 0.53
▸ NPC1 O15118 1/20 0.46
▸ RAB9A P51151 1/20 0.46
▸ TDP1 Q9NUW8 1/20 0.46
▸ PRMT1 Q99873 1/20 0.44
▸ AKR1C3 P42330 1/20 0.44
▸ AKR1C2 P52895 1/20 0.44
▸ MAPT P10636 1/20 0.40
▸ SNCA P37840 1/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ LMNA P02545 1/20 0.40
▸ TP53 P04637 1/20 0.40
▸ PTGS2 P35354 1/20 0.39
▸ CYP1A2 P05177 3/20 0.39
▸ HSD11B1 P28845 1/20 0.39
▸ CA12 O43570 1/20 0.39
▸ CA1 P00915 1/20 0.39
▸ CA2 P00918 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17157614 1.00 MAOB (0.59) MAOBMAOAVCPNPC1RAB9A
SCHEMBL290719 0.84 AKR1C3 (0.62) MAOBMAOAVCPTDP1PRMT1
SCHEMBL290718 0.84 AKR1C3 (0.62) MAOBMAOAVCPTDP1PRMT1
SCHEMBL248732 0.84 PTGS2 (0.53) MAOBMAOASNCAPTGS2CYP1A2
SCHEMBL248733 0.84 PTGS2 (0.53) MAOBMAOASNCAPTGS2CYP1A2
SCHEMBL31202474 0.84 PTGS2 (0.53) MAOBMAOASNCAPTGS2CYP1A2
SCHEMBL8149850 0.83 MAOB (0.57) MAOBMAOAVCPNPC1RAB9A
SCHEMBL8149848 0.83 MAOB (0.57) MAOBMAOAVCPNPC1RAB9A
SCHEMBL31528750 0.81 MAOB (0.56) MAOBMAOAVCPPRMT1ALDH1A1
SCHEMBL6821816 0.81 PTPN11 (0.46) MAOBMAOAALDH1A1CYP1A2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9376420-B2 4,5-dihydro-1H-pyrazole derivative or salts thereof, and pharmaceutical composition comprising same YUHAN CORPORATION (KR) 2016-06-28 — — US disclosed
US-20150291563-A1 4,5-DIHYDRO-1H-PYRAZOLE DERIVATIVE OR SALTS THEREOF, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME YUHAN CORPORATION (KR) 2015-10-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150291563-A1 4,5-DIHYDRO-1H-PYRAZOLE DERIVATIVE OR SALTS THEREOF, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME NR1H3, NR1H2, NR1H4 MAOB 4828/4885MAOA 4862/4885VCP 2619/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback